DELIVERY ORDER
Active75F40126F19010
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$1.3M
obligated · signed 6 days ago
CHARACTERIZATION AND STABILITY ASSESSMENT OF ADDITIVES IN ENDS PRODUCTS
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
RESEARCH TRIANGLE INSTITUTE
Contract 75F40126F19010
UEI
JJHCMK4NT5N3
Parent Company
RESEARCH TRIANGLE INSTITUTE
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$1,319,219
Base + Exercised Options
$1,319,219
Total Ceiling Value
$1,319,219
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
MEDICAL LABORATORIES
PSC
SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40122D00008
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.